Prognostic Factors and Optimal Empiric Therapy for Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales Bacteremia
Cureus · 27.11.2025
DOI: 10.7759/cureus.97980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 27.11.2025. Verfasst von Tadashi Maeda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine and Emergency Care, Toho University School of Medicine, Tokyo, JPN. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Medicine and Emergency Care, Toho University School of Medicine, Tokyo, JPN.
- Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, JPN.
Zitieren
APA
Maeda, T., Harada, S., Nakase, D., Nakamura, Y., Mori, T., Kashiwagi, K., Sato, T., Miyazaki, T., & Sasaki, Y. (2025). Prognostic Factors and Optimal Empiric Therapy for Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales Bacteremia. Cureus. https://doi.org/10.7759/cureus.97980
Vancouver
Maeda T, Harada S, Nakase D, Nakamura Y, Mori T, Kashiwagi K, et al. Prognostic Factors and Optimal Empiric Therapy for Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales Bacteremia. Cureus. 2025. doi:10.7759/cureus.97980
BibTeX
@article{Maeda2025,
author = {Maeda, Tadashi and Harada, Sohei and Nakase, Dai and Nakamura, Yusuke and Mori, Takeo and Kashiwagi, Katsuhito and Sato, Takahiro and Miyazaki, Taito and Sasaki, Yosuke},
title = {Prognostic Factors and Optimal Empiric Therapy for Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales Bacteremia},
journal = {Cureus},
year = {2025},
doi = {10.7759/cureus.97980}
}
EUVIMED